ORIBIOTECH LTD
Get an alert when ORIBIOTECH LTD files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£13M
-63.5% vs 2023
Net assets
£23M
-44.5% vs 2023
Employees
64
+8.5% vs 2023
Profit before tax
-£22M
-5.9% vs 2023
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
3 officer resignations in last 12 months
Multiple officers have left the board recently — see the People section for who.
Net assets
2-year trend · vs Industrials median
Accounts
2-year trend · Δ = latest vs prior filed period · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 | Δ vs prior |
|---|---|---|---|---|
| Turnover | £106,000 | £474,000 | +347.2% | |
| Operating profit | -£22,481,000 | -£23,229,000 | -3.3% | |
| Profit before tax | -£20,946,000 | -£22,173,000 | -5.9% | |
| Net profit | -£16,667,000 | -£19,330,000 | -16% | |
| Cash | £35,148,000 | £12,833,000 | -63.5% | |
| Total assets less current liabilities | — | — | — | |
| Net assets | £41,843,000 | £23,222,000 | -44.5% | |
| Equity | £41,843,000 | £23,222,000 | -44.5% | |
| Average employees | 59 | 64 | +8.5% | |
| Wages | £6,056,000 | £6,763,000 | +11.7% | |
| Directors' remuneration | £695,000 | £665,000 | -4.3% |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Gearing (liabilities / total assets) | 6.1% | 9.4% | |
| Current ratio | 15.94x | 9.27x |
Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Margin ratios are hidden where reported turnover is too small relative to profit to yield a meaningful figure — typical of holding companies whose income is mostly subsidiary dividends rather than trading revenue. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- IFRS
- Reporting scope
- Consolidated group
- Auditor
- RSM UK Audit LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The Directors have concluded that the Group is a going concern at the date of approval of these financial statements Further information can be found in note 1.2 of the financial statements.”
Group structure
- ORIBIOTECH LTD · parent
- Ori Biotech North America Inc 100%
Significant events
- “On December 10, 2024, Oribiotech also announced a collaboration with Fresenius Kabi to advance modular, scalable manufacturing of cell and gene therapies.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
5 active · 9 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| FOSTER, Jason Charles | Director | 2019-07-29 | Dec 1974 | American |
| HAY, Jonathan Russell | Director | 2020-08-21 | Sep 1961 | British,American |
| JACKSON, Andrea Liapis | Director | 2024-02-01 | Aug 1978 | American |
| JENKINS, Annalisa Mary, Dr | Director | 2021-06-30 | Jun 1965 | British |
| MEISTER, Paul Matthew | Director | 2021-12-23 | Oct 1952 | American |
Show 9 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BARGE, Alan John, Dr | Director | 2019-07-29 | 2020-08-21 |
| CLARE, Barry | Director | 2019-07-29 | 2026-01-09 |
| KEDAR, Sharon | Director | 2020-08-21 | 2020-09-22 |
| MASON, Christopher, Professor | Director | 2019-07-29 | 2026-01-09 |
| MASON, Christopher | Director | 2015-09-02 | 2018-01-15 |
| SOCHA, Pierre Robert | Director | 2019-07-29 | 2021-12-23 |
| TRACEY, William Patrick | Director | 2018-03-26 | 2020-08-21 |
| VERAITCH, Farlan Singh | Director | 2015-09-02 | 2026-01-09 |
| WIESCHHAUS, Adam Joseph | Director | 2020-09-22 | 2024-02-01 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Mr Farlan Singh Veraitch | Individual | Shares 25–50% | 2016-09-01 | Ceased 2019-08-20 |
Filing timeline
Last 20 of 103 total filings
Material constitutional events — rename, articles re-file, resolution
- 2026-01-15 MA Memorandum articles
- 2026-01-15 RESOLUTIONS Resolution
- 2025-11-21 RESOLUTIONS Resolution
- 2025-02-18 RESOLUTIONS Resolution
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-03-12 | SH01 | capital | Capital allotment shares | |
| 2026-01-30 | SH10 | capital | Capital variation of rights attached to shares | |
| 2026-01-30 | SH08 | capital | Capital name of class of shares | |
| 2026-01-16 | TM01 | officers | Termination director company with name termination date | |
| 2026-01-16 | TM01 | officers | Termination director company with name termination date | |
| 2026-01-16 | TM01 | officers | Termination director company with name termination date | |
| 2026-01-15 | MA | incorporation | Memorandum articles | |
| 2026-01-15 | RESOLUTIONS | resolution | Resolution | |
| 2025-11-21 | RESOLUTIONS | resolution | Resolution | |
| 2025-11-20 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2025-09-05 | AD01 | address | Change registered office address company with date old address new address | |
| 2025-07-29 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2025-07-29 | SH01 | capital | Capital allotment shares | |
| 2025-07-29 | SH01 | capital | Capital allotment shares | |
| 2025-07-24 | AA | accounts | Accounts with accounts type group | |
| 2025-06-16 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2025-02-18 | RESOLUTIONS | resolution | Resolution | |
| 2024-12-05 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2024-07-25 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2024-07-25 | SH01 | capital | Capital allotment shares |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 15
- Capital events
- 6
- Officers appointed
- 0
- Officers resigned
- 3
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.